Delivery Order SPE2DB22D3501-SPE2DB24FUN95
- Not listed
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,266.24 firm fixed-price delivery order is for the supply of Topamax 25 mg sprinkle capsules. The contract has an ultimate completion date of June 10, 2022 and was awarded on June 9, 2022. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Topamax 25 mg sprinkle capsules. The contract, valued at $13,153.35, is a Firm Fixed Price Delivery Order with a completion date of December 28, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical division to...
- This federal contract award was made by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,828.80 firm-fixed-price delivery order is for the supply of Topamax 25 mg sprinkle capsules. The contract is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The contract is for the delivery of Topamax 25 mg sprinkle capsules, a pharmaceutical product, to support military treatment programs and facilities. The contract is a firm fixed price delivery order with a potential value of $1,767.72 and a completion date of January 30, 2024. No set-aside designation was...
- This federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of Topamax 25 mg sprinkle capsules. The contract, valued at $4,651.73, is a firm fixed-price delivery order with a completion date of June 18, 2024. It is not designated as a set-aside contract. Amerisourcebergen Drug Corp is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of 4,561,784,974 units of Topamax 25 mg sprinkle capsules. The $1,445.50 firm fixed-price delivery order has an ultimate completion date of August 14, 2023. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which does...
- This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $12,518.04, is a delivery order for the supply of Topiramate (Topamax) 25 mg sprinkle capsules. The contract has an ultimate completion date of January 11, 2024 and is a firm fixed-price contract. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,280.38 firm fixed price delivery order is for the supply of Topamax 15 mg sprinkle capsules. The contract has a completion date of June 5, 2024 and was awarded on June 4, 2024. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of Topamax 25 mg sprinkle capsules. The $2,356.12 firm fixed-price Delivery Order (SPE2DB22D1106|SPE2DB25FDLT2) has a completion date of November 18, 2024 and was awarded on November 15, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Topamax 25 mg sprinkle capsules, a neurological medication, with a ceiling value of $3,734.66 and a performance period through May 2025. The contract is a firm fixed-price, non-set-aside award, indicating open competition. AmerisourceBergen Drug Corp holds a larger $999,999,999.00...
- SPE2DB22D3501Indefinite Delivery Contract
- SPE2DB22D3501-SPE2DB24FUN95Delivery Order
This federal contract award was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,521.47, is for the delivery of Topamax 25 mg sprinkle capsules. It is a firm-fixed-price delivery order contract type with a completion date of February 13, 2024. The contract is not designated as a set-aside, indicating open competition. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which serves as a critical supplier of pharmaceutical products and medical supplies to various government agencies, particularly the Department of Defense (DoD) and Department of Veterans Affairs (VA) healthcare systems. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at up to $999,999,999.00, which runs through December 2026. This IDC serves as the primary vehicle for the company to deliver a comprehensive range of pharmaceutical products and medical supplies to support military treatment facilities and veterans' healthcare programs worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.5k | 2/12/24 |